I-CAS 177036-94-1 Ubunyulu > 99.0% (HPLC) I-API Factory High Purity
Ubonelelo ngezoRhwebo (CAS: 177036-94-1) abaPhakathi abaNxulumeneyo:
CAS: 177036-94-1
I-Methyl 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoate CAS: 178306-47-3
I-2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS: 178306-51-9
(S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropionic Acid CAS: 178306-52-0
L-Proline Methyl Ester Hydrochlorid CAS: 2133-40-6
4,6-Dimethyl-2-(Methylsulfonyl)pyrimidine CAS: 35144-22-0
Igama leMchiza | (S) -2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-Methoxy-3,3-Diphenylpropionic Acid |
Izithethantonye | (+-)-(2S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-Methoxy-3,3-Diphenylpropanoic Acid |
Inombolo yeCAS | 177036-94-1 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C22H22N2O4 |
Ubunzima beMolekyuli | 378.43 |
Ukujikeleziswa okuthe ngqo [α]D20 | +170.0 ° ukuya +176.0 ° (C=0.5, MeOH) |
Indawo yokunyibilika | 172.0~178.0℃(dec.) |
Ukunyibilika | Inyibilika kakhulu kwiMethanol;Inyibilika kwi-Ethanol, i-acetone;Ayinyibilikiyo emanzini |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Umgubo oMhlophe okanye oMhlophe |
Ukuchongwa | I-HPLC;NMR;I-LC-MS |
Izinto ezinxulumeneyo | |
Ukungacoceki komntu | ≤0.50% |
Ukungcola ngokupheleleyo | <1.00% |
Ilahleko ekomisweni | ≤0.50% |
Intsalela kwi-Ignition | ≤0.20% |
Iintsimbi ezinzima | ≤20ppm |
Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | AbaPhakathi bamayeza |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
(CAS: 177036-94-1) APIngumchasi we-endothelin-A (ETA) okhethiweyo owaziswa kunyango lomlomo lwezigulane ezine-pulmonary arterial hypertension (PAH), ukuphucula umthamo wokuzilolonga kunye nokulibazisa ukonakala kweklinikhi.I-PAH isifo esinqabileyo semibhobho encinci ye-pulmonary ebonakaliswe ngokunyuka kwe-vascular kunye nokulungiswa kwakhona, okubangelwa ukunyuka okuqhubekayo kwi-pulmonary vascular resistance and pulmonary arterial pressure, kwaye ekugqibeleni, ukungaphumeleli kwe-ventricular kunye nokufa kwangaphambi kwexesha.Iimpawu zakwangoko ze-PAH ziquka ukuphelelwa ngumphefumlo ngokuthe ngcembe, ukudinwa, ukubetha kwentliziyo, ukudumba, nokuquleka.I-Endothelin-1 (ET-1), i-vasoconstrictor enamandla kunye ne-mitogen ye-muscle egudileyo, inegalelo eliphambili ekukhawuleziseni kwesi sifo, kwaye iziphumo zayo zixutywe ngokusetyenziswa kwe-ETA kunye ne-ETB receptors.NgoJuni ka-2007, i-FDA inike imvume (i-CAS: 177036-94-1) i-API yonyango lwe-PAH kanye ngosuku.